Guidelines for reporting trial protocols and completed trials modified due to the COVID-19 pandemic and other extenuating circumstances: The CONSERVE 2021 Statement.

Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement – JAMA

Commentaries on Twitter

CONSERVE offers guidance that could help improve the transparency, quality, and completeness of reporting important modifications to trials in extenuating circumstances https://t.co/IiWgs7dtpQ

— JAMA (@JAMA_current) June 21, 2021

Did your clinical trial require modification due to #COVID19? Check out these reporting guidelines in @JAMA_current. https://t.co/Oy21gmrRlN

— Sherry Pagoto (@DrSherryPagoto) June 21, 2021